AYTU BIOPHARMA, INC — Director's Dealing 2016

Sep 2, 2016

SEC Form 4/A — Form 4/A

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-05-06

Reporting Person: Disbrow Joshua R. (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-06	Warrant to Purchase Common Stock	$0.50	P	250000	Acquired	2021-05-06	Common Stock (250000)	Direct

Footnotes

F1: These warrants were purchased, together with shares of common stock, on May 6, 2016, and were omitted from the Reporting Person's original Form 4 filed on May 16, 2016 to report the purchase, and were also omitted from the two Forms 4 filed by the Reporting Person after the original Form 4 was filed. This amended Form 4 does not give effect to a 1-for-12 reverse stock split effected on June 30, 2016.